CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4/A Open-market sale Director sold 62,925 shares at $29.70 ($1,869,168)
- 4 Open-market sale President sold 100,000 shares at an average $35.02 ($3,502,385)
- 4 Grant or award Chief Business Officer acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 40,198 shares at an average $24.93 ($1,002,194)
- 4 Open-market buy 10% owner bought 90,742 shares at an average $24.08 ($2,184,960)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 72,934 shares at an average $29.85 ($2,176,898)
- 4 Exercise or conversion Chief Executive Officer acquired 21,500 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 741 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 741 shares (to pay taxes)
- 4 Shares withheld for taxes Ho Tony W gave up 14,631 shares (to pay taxes)
- 4 Open-market sale Director sold 7,500 shares at $62.00 ($465,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 18 of 26 · 502 filings